Jorge A. Flores

Emergency Medicine
100 W California Blvd
Pasadena, CA 91105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Journal: Vaccines
Published: June 25, 2026

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Journal: Vaccines
Published: April 28, 2026

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.

Journal: Vaccine
Published: May 20, 2024

Deep Hair Phenomics: Implications in Endocrinology, Development, and Aging.

Deep Hair Phenomics: Implications in Endocrinology, Development, and Aging.

Journal: The Journal of investigative dermatology
Published: April 02, 2024

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Viruses
Published: July 14, 2023

Controlled Human Infection Models To Accelerate Vaccine Development.

Controlled Human Infection Models To Accelerate Vaccine Development.

Journal: Clinical microbiology reviews
Published: July 21, 2022

Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652).

Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652).

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 23, 2021

Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants.

Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants.

Journal: Vaccine
Published: March 01, 2021

Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants.

Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants.

Journal: Vaccine
Published: October 01, 2020

Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva).

Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva).

Journal: Vaccine
Published: September 04, 2020

Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.

Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 31, 2020

A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1).

A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1).

Journal: Vaccine
Published: September 06, 2019
Showing 1-12 of 38

Last Updated: 09/26/2026